News

Stakeholders confirm support for strengthened EU cooperation on HTA

Stakeholders confirm support for strengthened EU cooperation on HTA

On 9th July 2018, over 300 policy makers, healthcare providers, patient representatives and other experts discussed their views about the future cooperation on Health Technology Assessment (HTA). The discussions indicated that, after 20 years of joint work, HTA should be given a fair chance to become more structured, sustainable and efficient, better allowing for an optimal use of resources and sharing of expertise across the EU.

For Commissioner Vytenis Andriukaitis, the input from patients, health professionals and industry in the HTA discussion is essential:

We now have an opportunity to establish a mechanism that ensures that HTA is used to its maximum potential throughout the EU. I believe that joint assessments would not only help patients to have access to the most effective health technologies, but would also contribute to the sustainability of health systems. The broad involvement of stakeholders also ensures quality and predictability. Moreover, I believe that our proposal would bring more transparency in the HTA processes in the EU”.

After the plenary opening session with the Commissioner, the European Parliament’s rapporteur, Soledad Cabezón Ruiz, Clemens Auer of the Austrian Health Ministry, and EESC rapporteur Dimitris Dimitriadis, the participants gave recommendations on three major topics:

  • Engaging with patients and clinicians on HTA. Transparent and systematic engagement with stakeholders is needed, both on product-specific reports and on a broader strategic level. The involvement of patients and health professionals in the joint clinical assessment guarantees that the reports consider patient-relevant endpoints. Appropriate resources such as training are needed to enable their contributions.
  • Generating evidence that meets the needs of patients and health system decision makers. A higher involvement of stakeholders will generate the relevant evidence that meets the needs of the health system decision-makers (including regulators, HTA and payer bodies) and that is also relevant for patients. The issue of transparency is key for the success and acceptance of the exercise.
  • Managing uncertainty in the post-launch phase. Post-launch evidence is a key component of the re-assessment of health technologies. Registries and real world data form an important part of the body of evidence on the effectiveness and efficacy of medical devices. The EU’s Digital Single Market offers numerous opportunities for interoperable ICT solutions, common standards, data security and digital competences.

The stakeholders input will feed in the work of the current cooperation and in developing of the future approach post-2020.

More information 


Article Source: http://ec.europa.eu/newsroom/sante/newsletter-specific-archive-issue.cfm?archtype=specific&newsletter_service_id=327&newsletter_issue_id=9886&page=1&fullDate=Fri%2007%20Sep%202018&lang=default

NEWS​

Related News

The Miguel Delibes Cultural Center has been the epicenter of the Sectoral Meeting on Care and Innovation that commemorates the 10th Anniversary of the SIVI Cluster

16 Apr 2024
This conference, organized by the SIVI Cluster, was presented as a space for reflection, exchange and recognition of the advances and outstanding cont...

CRANE: pre-commercial procurement project. FundeSalud participate in the co-creation sessions of the CRANE Project in Copenhagen

16 Apr 2024
Three European companies are designing a prototype of a possible technological solution for patients with chronic diseases (Diabetes, Cardiovascular D...

The use of innovation to improve the social health and care sector

16 Apr 2024
On April 9th, the online presentation day of the AEI 2023 Project took place; conference organized by the Cluster of Innovative Solutions for Independ...

Open Market Consultation Published for AI-Based Solutions in Healthcare in Catalonia

16 Apr 2024
The Catalan healthcare system has announced an upcoming open market consultation aimed at sourcing AI-based solutions to prevent medication-related he...

HealthTEC.SG – Accelerating health technology innovations through global partnerships

16 Apr 2024
The Singapore health technology ecosystem is a rapidly growing ecosystem with a high density of startups, small-and-medium sized companies, and multin...

ECOS, the First Chilean Health innovation Ecosystem. Tackling the health system challenges through Innovation Ecosystems

16 Apr 2024
Learn about ECOS, Chile's pioneering health innovation ecosystem, on April 24th at 15:00 (GMT-4) as we come together to revolutionize healthcare in Ch...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *